α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
about
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's diseaseAlpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's diseaseCSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's diseasePotential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Tau protein modifications and interactions: their role in function and dysfunction.CSF Apo-E levels associate with cognitive decline and MRI changesMini review: linkage between α-Synuclein protein and cognition.Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects.Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.Therapeutic implications of how TNF links APOE, P-tau, α-synuclein, β-amyloid, and insulin resistance in neurodegenerative diseases
P2860
Q26801629-B40C60AE-C378-4CC9-B0EF-B1A1795983FFQ27322563-DBFCB9A7-1B48-4EBE-A922-A29B9B5C4FF8Q30405991-7DC3CF3A-F7C0-45F3-9B32-F241A7A221D5Q30971403-4170F199-896F-4E0A-A10F-2CEEA8FFBE0FQ34627859-9B5828C8-0BF7-4656-85C9-557D492B3703Q34714560-2D2BC84E-101B-40C0-B16B-75D8FAB152BBQ35083125-BEF41A2F-4A23-4064-8F1D-8F0AA7AD881BQ35151444-51EBC7F8-4444-4FE4-80CB-3B673AF9C6C4Q36139579-DFB3F563-62F4-4710-A38F-8C65DF3280DBQ36245278-62DD48EB-6852-480F-9A68-A86847644F2CQ37266166-12C46905-DF3A-453A-9EF3-E03B3566D742Q37297626-0E0DA5BB-41CB-4C08-A958-1E33E95B7B7CQ37684106-2FF9D9A1-496D-4D9A-9471-7EC563B0B723Q37705204-AE11E258-3A16-4666-9BA9-1F82C1712F3CQ38401326-1E11A709-E043-44C6-8069-71D89CD18615Q40017984-BFE8D742-37F3-4381-BFD6-B591D2A617E4Q42378886-B8A2B6DA-955E-4D2F-8BD6-4A8EB0E6C203Q42656279-82FD7C9B-FC48-43B9-A3D2-A65C5DAF3629Q49613405-E3D91D4E-DA2B-4D34-94ED-B10DFE485D1FQ50023771-E5508872-347A-405E-84F2-BC650846A668Q53396870-EDE53021-ACAD-4ECC-A9D6-AED677773B6BQ56344227-C13FBF56-13FD-4FCD-960A-DFFF34A30425
P2860
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
@en
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.
@nl
type
label
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
@en
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.
@nl
prefLabel
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
@en
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.
@nl
P2093
P2860
P921
P356
P1476
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
@en
P2093
Carmen Ginghina
Changqin Liu
Jing Zhang
P2860
P304
P356
10.3233/JAD-130458
P577
2013-01-01T00:00:00Z